InspireMD Inc (NYSEAMERICAN:NSPR) saw a significant decline in short interest in the month of November. As of November 30th, there was short interest totalling 738,488 shares, a decline of 6.6% from the November 15th total of 790,344 shares. Based on an average daily volume of 1,848,702 shares, the short-interest ratio is presently 0.4 days. Currently, 10.2% of the company’s shares are short sold.

InspireMD (NYSEAMERICAN:NSPR) opened at $0.13 on Tuesday. InspireMD has a fifty-two week low of $0.02 and a fifty-two week high of $3.97.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/12/inspiremd-inc-nspr-short-interest-update-2.html.

InspireMD Company Profile

InspireMD, Inc is a medical device company. The Company is focusing on the development and commercialization of its MicroNet stent platform technology for the treatment of vascular and coronary disease. Its MicroNet, a micron mesh sleeve, is wrapped over a stent to provide embolic protection in stenting procedures.

Receive News & Ratings for InspireMD Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InspireMD Inc and related companies with MarketBeat.com's FREE daily email newsletter.